Culturing and screening of tissue models
Mimetas has raised €22M across 4 funding rounds from 8 investors, most recently a round in Aug 2026. Based in Leiden, Netherlands; founded 2013; active in Healthtech. Data as of 21 Sept 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-08-10 | Other | — | Bruker Corporation | View deal → |
| 2018-02-01 | Series B | €16M | Aglaia Oncology Fund II,Cathay Venture,European Life Sciences Growth Fund,InnovationQuarter,Korys,Oost NL | View deal → |
| 2014-10-01 | Series A | €4.1M | Zeeuws InvesteringsFonds | View deal → |
| 2014-09-01 | Seed | €1.2M | — | View deal → |
